Healthcare, biotechnology & medical AI Product
InferRead Lung CT.AI assists with review of pulmonary nodules
Infervision’s InferRead Lung CT.AI flags possible pulmonary nodules on chest CT for radiologist review. A later decision under the same device name describes measurements and comparison features. [1][2]
What it does
The FDA cleared the K192880 submission on July 2, 2020, and a later submission, K240554, on May 16, 2025. [1][2]
Why it matters
The second filing helps distinguish a nodule mark from measurements and other supporting information available in the documented later version. [1][2]
Who it’s for
The tool is labeled for radiologists reviewing chest CT in the defined screening context. [1][2]
Key dates
Where it fits
The documented software presents annotations on relevant studies. The later filing also describes comparison and quantitative outputs. [1][2]
Limits and trade-offs
The FDA summaries define an eligible population, usable image series and specific nodule-detection scope. The outputs assist radiologist review. [1][2]
Sources and verification
Catalog evidence checked How we verify records
- Primary source FDA 510(k) decision for InferRead Lung CT.AI (K192880)
- Primary source FDA 510(k) decision for InferRead Lung CT.AI (K240554)
Related profiles
Healthcare, biotechnology & medical AI
Sleep Analysis Module (SAM)
Neurotronics (Nihon Kohden)
The module estimates sleep time from a signal captured during its intended sleep-testing workflow.
Healthcare, biotechnology & medical AI
Heartvue.Proton
Heartvue.ai
It is software for analyzing cardiac MRI images within its documented intended-use scope.
Healthcare, biotechnology & medical AI
ThinkSono Guidance
ThinkSono
Provides guidance during acquisition of lower-extremity compression ultrasound images for review by healthcare professionals.